$MREO Balance Sheet | Understand Stock

$MREO

$0.29 +$0.02 (6.07%) Close

$MREO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019
Property, plant and equipment
Intangible assets
Total non-current assets
Prepayments
R&D tax credits
Other taxes receivable
Other receivables
Cash and short-term deposits
Total current assets
Total assets
Provisions
Convertible loan notes
Warrant liability
Lease liability
Other liabilities
Total non-current liabilities
Trade and other payables
Accruals
Current tax liabilities
Contingent consideration liability
Total current liabilities
Total liabilities
Total equity and liabilities
Net assets
Issued capital
Share premium
Other capital reserves
Employee Benefit Trust shares
Other reserves
Accumulated losses
Translation reserve
Assets
Current assets:
Cash and cash equivalents
Prepaid expenses and other current assets
Research and development incentives receivables
Total current assets
Property and equipment, net
Operating lease right-of-use assets, net
Intangible assets, net
Total assets
Liabilities
Current liabilities:
Accounts payable
Accrued expenses
Convertible loan notes - current
Warrant liabilities - current
Operating lease liabilities - current
Other current liabilities
Total current liabilities
Convertible loan notes - non-current
Warrant liabilities - non-current
Operating lease liabilities- non-current
Other non-current liabilities
Total liabilities
Shareholders' Equity
Ordinary shares, par value 0.003 per share; 798,093,044 shares issued at June 30, 2026 (December 31, 2025: 795,658,504)
Treasury shares
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders' equity
Total liabilities and shareholders' equity

Comments